CYP2C19 and effect of clopidogrel for secondary prevention of major ischemic events: systematic review and meta-analysis
Preprint in medRxiv (August 2023)
The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.
Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives
Article in Expert Opinion on Drug Metabolism & Toxicology (December 2022)
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
Article in Genetics Research (October 2022)